| Morningstar Fund Report | 03/04/2025 |  |
Brandes European Value Fund A Euro Acc |
| Performance History | 31/03/2025 |
| Growth of 1,000 (GBP) | Advanced Graph |
 | Fund | 14.7 | 0.1 | 21.7 | 11.8 | 6.1 |
| +/-Cat | -0.5 | 2.7 | 9.3 | 9.3 | -3.2 |
| +/-B’mrk | - | - | 8.5 | 7.3 | -5.9 |
| Category: Europe Large-Cap Value Equity | ||||||
| Category Benchmark: Morningstar Dev Europe Val ... | ||||||
| Key Stats | ||
| NAV 02/04/2025 | EUR 45.13 | |
| Day Change | -0.07% | |
| Morningstar Category™ | Europe Large-Cap Value Equity | |
| ISIN | IE0031574647 | |
| Fund Size (Mil) 02/04/2025 | EUR 759.16 | |
| Share Class Size (Mil) 02/04/2025 | EUR 94.12 | |
| Max Initial Charge | 5.00% | |
| Ongoing Charge 03/03/2025 | 1.69% | |
| Morningstar Research |
| Analyst Report | 31/01/2025 Mathieu Caquineau, Senior Principal Morningstar, Inc |
Brandes European Value is led by veteran value investors who apply a disciplined and long-term-oriented approach. Risks are high, though, and investors should approach the fund prudently. But sized appropriately in a portfolio, this strategy... | |
| Click here to read this analyst report on the underlying fund. | |
| Morningstar Pillars | |
|---|---|
| People | 25 |
| Parent | 24 |
| Process | 24 |
| Performance | |
| Price | |
| Investment Objective: Brandes European Value Fund A Euro Acc |
| The investment objective of the Fund is to seek long-term capital appreciation. There is no limitation on the market capitalisation of the issuers in which the Fund may invest. At least two thirds of the investments of the Fund (in terms of total assets) will be in equity securities of issuers located or active mainly in Europe (“European Equities”). Equity securities include common and preferred stock, warrants, rights and depository receipts. |
| Returns | |||||||||||||
|
| Management | ||
Manager Name Start Date | ||
Luiz Sauerbronn 01/02/2013 | ||
Amelia Morris 14/01/2003 | ||
| Click here to see others | ||
Inception Date 17/07/2003 | ||
| Category Benchmark | |
| Fund Benchmark | Morningstar Benchmark |
| MSCI Europe NR EUR | Morningstar Dev Europe Val TME NR EUR |
| Portfolio Profile for Brandes European Value Fund A Euro Acc | 28/02/2025 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
| Top 5 Holdings | Sector | % |
 Heineken Holding NV |  Consumer Defensive | 3.12 |
| GSK PLC |  Healthcare | 2.72 |
 Sanofi SA | Healthcare | 2.59 |
| BNP Paribas Act. Cat.A |  Financial Services | 2.48 |
| The Swatch Group AG |  Consumer Cyclical | 2.31 |
 | ||
Increase Decrease  New since last portfolio | ||
| Brandes European Value Fund A Euro Acc | ||
| Growth Of 1000 (GBP) | 31/03/2025 |
|
| Annual Returns (GBP) | 31/03/2025 | |||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 31/03 | |
| Price Return | -10.12 | 10.24 | 0.63 | 14.67 | 0.08 | 21.72 | 11.84 | 6.09 |
| +/- Category | 3.32 | -3.76 | 3.23 | -0.51 | 2.74 | 9.33 | 9.27 | -3.22 |
| +/- Category Index | - | - | - | - | - | 8.53 | 7.25 | -5.90 |
| % Rank in Category | 14 | 88 | 24 | 60 | 34 | 3 | 2 | 86 |
| Trailing Returns (GBP) | 02/04/2025 | ||
| Total Returns | +/- Category | +/- Category Index | |
| 1 Day | -0.07 | -0.30 | 0.25 |
| 1 Week | -2.22 | -0.07 | -0.51 |
| 1 Month | -2.99 | -2.45 | -3.59 |
| 3 Months | 5.28 | -4.10 | -6.19 |
| 6 Months | 3.42 | -2.20 | -6.76 |
| YTD | 5.85 | -3.53 | -6.67 |
| 1 Year | 12.47 | 4.60 | -0.83 |
| 3 Years Annualised | 14.20 | 5.11 | 3.20 |
| 5 Years Annualised | 17.73 | 3.27 | 1.94 |
| 10 Years Annualised | 7.15 | 1.42 | 0.49 |
| Category: Europe Large-Cap Value Equity | |||
| Category Index: Morningstar Dev Europe Val TME NR EUR | |||
| Quarterly Returns (GBP) | 31/03/2025 | |||
| Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
| 2025 | 6.09 | - | - | - |
| 2024 | 5.38 | 3.51 | 5.81 | -3.10 |
| 2023 | 8.72 | 0.22 | 4.27 | 7.14 |
| 2022 | -3.83 | -3.15 | -6.61 | 15.07 |
| 2021 | 8.66 | 5.79 | 0.42 | -0.66 |
| 2020 | -25.96 | 17.81 | -2.00 | 17.73 |
| Morningstar Rating™(Relative to Category) | 28/02/2025 | ||||||||||||||||||||
| |||||||||||||||||||||
| Category : Europe Large-Cap Value Equity | Click here to see our Methodology | ||||||||||||||||||||
| Volatility Measurements | 31/03/2025 | ||||||||||
| |||||||||||
| Modern Portfolio Statistics | 31/03/2025 | 31/03/2025 |
| Standard Index | Best Fit Index | |
| Morningstar Dev Europe Val TME NR EUR | Morningstar Dev Ezn Sml TME NR EUR | |
| 3-Yr Beta | 1.06 | 0.84 |
| 3-Yr Alpha | 2.90 | 10.83 |
| Investment Style Details | 28/02/2025 | ||||||||||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
| Category: Europe Large-Cap Value Equity | |||||||||||||||||||||||||||||||||||||||||
| Asset Allocation | 28/02/2025 |
| ||||||||||||||||||||||||||
| World Regions | 28/02/2025 | ||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||
| Category: Europe Large-Cap Value Equity | |||||||||||||||||||||||||||||||||||||||||||
| Sector Weightings | 28/02/2025 | |||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| Category: Europe Large-Cap Value Equity | ||||||||||||||||||||||||||||||||||
Basic Materials
Utilities
Communication Services
Energy
Technology| Top 10 Holdings | 28/02/2025 |
| Portfolio NEW | |
| Total Number of Equity Holdings | 69 |
| Total Number of Bond Holdings | 0 |
| Assets in Top 10 Holdings | 24.38 |
| Name | Sector | Country | % of Assets | ||
| Heineken Holding NV | | Netherlands | 3.12 | ||
| GSK PLC | | United Kingdom | 2.72 | ||
| Sanofi SA | | France | 2.59 | ||
| BNP Paribas Act. Cat.A | | France | 2.48 | ||
| The Swatch Group AG | | Switzerland | 2.31 | ||
| Deutsche Post AG |  | Germany | 2.30 | ||
| Grifols SA Participating Preferred | | Spain | 2.28 | ||
| UBS Group AG | | Switzerland | 2.23 | ||
| Kering SA | | France | 2.21 | ||
| Smith & Nephew PLC | | United Kingdom | 2.15 | ||
| Increase Decrease New since last portfolio | |||||
| Category: Europe Large-Cap Value Equity | |||||
| Management | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| |
| Biography | |
| Luiz Sauerbronn, a limited partner of the firm’s parent company, is a Senior Analyst on the Industrials Research Team and a member of the International Large-Cap and Small-Cap Investment Committees. He is also a member of the Corporate Governance and Proxy Voting Committee. Prior to Brandes, Mr. Sauerbronn worked at J.P. Morgan, Banco Brascan (part of Brookfield) in Brazil, and Royal Dutch Shell. Earned his BS in economics from the Federal University of Rio de Janeiro and his MBA from Haas (UC Berkeley). His relevant experience began in 1995 & he joined Brandes in 2001. |
|
| Fund Manager | Amelia Morris |
| Manager Start Date | 14/01/2003 |
| Career Start Year | 1986 |
| Education |
| University of Chicago (Booth), M.B.A. |
| University of California–Davis, A.B. |
| |
| Biography | |
| Amelia Morris, a limited partner of the firm’s parent company, oversees equity research activities in the consumer sector and covers the European retail and telecom services industries. She is also a member of the International Large-Cap Investment Committee. Previously she’s been a member of the Emerging Markets Investment Committee, Investment Oversight Committee and Brandes Institute Advisory Board. Ms. Morris earned her AB from UC Davis and MBA from Booth-Chicago. She holds the CFA Institute Certificate in ESG Investing. Her relevant experience began in 1986, and joined Brandes in 1998. |
|
| Fund Manager | Shingo Omura |
| Manager Start Date | 01/02/2013 |
| Career Start Year | 2001 |
| Education |
| University of California–Berkeley (Haas), M.B.A. |
| Keio University, Tokyo, B.A. |
| |
| Biography | |
| Shingo Omura, a limited partner of the firm’s parent company, is a Senior Analyst & leader of the Health Care Research Team, with a primary emphasis on pharmaceutical companies. He is a member of the International Large-Cap Investment Committee & is the primary Product Coordinator for the Japan Equity strategy. He is also a member of the Corporate Governance & Proxy Voting Committee. Prior to Brandes, He worked as a sell-side Research Analyst in Japan. Earned his BA from Keio University in Tokyo, Japan, and MBA from Haas (UC Berkeley). His relevant experience began-2001 & joined Brandes - 2005 |
|
| Fund Manager | Jeffrey Germain |
| Manager Start Date | 31/01/2009 |
| Career Start Year | 2001 |
| Education |
| University of North Carolina, B.S. |
| |
| Biography | |
| Jeffrey Germain, CFA Director, Investments Group Jeff Germain, a limited partner of the firm’s parent company, is the Team Leader and Senior Analyst on the Basic Materials and Utilities Research Teams. He is also a member of the International Large-Cap Investment Committee. Prior to joining Brandes, Mr. Germain was a Financial Analyst with Harcourt and the CFO of Golf Destinations. Mr. Germain earned his BS in business administration with a concentration in finance from the University of North Carolina at Chapel Hill. His relevant experience began in 2001, when he joined Brandes. |
|
| Fund Manager | Brent Woods |
| Manager Start Date | 14/01/2003 |
| Career Start Year | 1986 |
| |
| Biography | |
| Brent V. Woods, CFA Executive Director Brent Woods, a limited partner of the firm’s parent company, is a member of the International Large-Cap Investment Committee, a member of the Investment Oversight Committee, and an officer of the firm’s general partner. Previously, he was the firm’s CEO and prior to that he was the Managing Director, Investments Group. Mr. Woods earned his AB from Princeton, his Master’s in international studies from Cambridge University, England, and his JD (cum laude) from Harvard. His relevant experience began in 1995, when he joined Brandes. |
| Fees and Expenses | ||||||||||||
| ||||||||||||
| Purchase Details | ||||||||
| ||||||||
| ||||||||